Artificial Intelligence (AI) is becoming increasingly crucial in medical research, and Helmholtz Munich is one of the world's leading institutions in this field. It can detect tumors as effectively as severe eye diseases.
The AiChemist project has officially started in September 2023 Coordinated by Helmholtz Munich the project is an Innovative Doctoral Training Network funded with 3 million euros provided by the Marie Skłodowska-Curie Actions (MSCA-DN) within the EU…
ScPoli Enables Multi-Scale Representations of Cells and Samples
The increasing amount of data recorded in medical research can only lead to scientific breakthroughs and essential therapies for patients if interpreted and analyzed correctly.…
Researchers at Helmholtz Munich and the Technical University of Munich have made significant progress in advancing high-resolution optoacoustic imaging for clinical use. Their innovative deep-learning framework, known as DeepMB, holds great promise…
A collaborative endeavor between computer scientists and diabetes researchers at Helmholtz Munich has yielded novel insights into the mechanisms underlying type 1 and type 2 diabetes. This collaboration has resulted in the creation of the first mouse…
Researchers from Helmholtz Munich have reached a significant milestone in precision medicine with their new publication on the 'Oncology Biomarker Discovery (OncoBird)' framework. This innovative approach aims to systematically identify actionable…
We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player or Twitter feeds. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:
